Abiogen Pharma consists of several therapeutic areas, including “Pain” with a complete and complementary line of products, available for both the management of inflammatory pain and non-inflammatory/neuropathic pain.
Furthermore, Abiogen has two class III medical devices for the viscosupplementation.
Pain, often associated with inflammation, is an everyday matter for physicians as it is the main reason patients require a visit.
Pain is often the symptom of various pathologies, acute or chronic, and besides the physical implications, it has always more frequently psychological/emotional consequences.
Today patients have the possibility of accessing therapies for the treatment of pain, thanks to a right provided by a law of the State. The aims of law 38/2010 are expressed in Article 1 which establishes the citizen’s right to receive such treatment with the respect of his/her dignity and autonomy, without discrimination (equity of access), and with the guarantee of receiving an appropriate quality treatment.
Law 38/2010 has not only defined “the patient’s right not to suffer uselessly” but has also mentioned how to ensure and safeguard this right.